Premier Alternatives

Reprieve Cardiovascular

Milford, MA · Founded 2018 · Privately Held (backing)

Developer of an acute decompensated heart failure (ADHF) treatment medical device designed to help patients experience life without limits. Reprieve Cardiovascular is based in Milford, MA and was founded in 2018. It was valued at $100 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $103 million across 5 recorded rounds; the latest was a $30.9 million early-stage round in May 2025.

PMV mark · valuation
$100.0M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$103.0M
Last round
Early Stage VC
May 2025
How much has Reprieve Cardiovascular raised?
$103.0Macross 5 recorded rounds · Jul 2020 – May 2025

Most recently, Reprieve Cardiovascular raised $30.9M in its Early Stage VC (May 2025).

Free account
More of Reprieve Cardiovascular with a free account
  • ·The complete investor list: 11 names
  • ·Watch Reprieve Cardiovascular: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Reprieve Cardiovascular round by round

5 rounds
May 2025Early Stage VC$30.9MSEC filing▮
12 investors participated
Sep 2024Debt$9.5MSEC filing▮
8 investors participated
Nov 2023Early Stage VC$12.1MSEC filing▮
7 investors participated
Apr 2022Early Stage VC$15.0MSEC filing▮
6 investors participated
Jul 2020Early Stage VC$15.0MSEC filing▮
6 investors participated

How much has Reprieve Cardiovascular raised?

Reprieve Cardiovascular has raised $103 million across 5 recorded rounds since 2020. The largest was a $9.5 million debt round in Sep 2024; the most recent was a $30.9 million early-stage round in May 2025.

Reprieve Cardiovascular has filed 6 Form Ds with the SEC since 2020, most recently in Jun 2025 ($30.9 million sold to 12 investors).

Reprieve Cardiovascular investors

11 investors are on record for Reprieve Cardiovascular, including Deerfield Management, Arboretum Ventures, Lightstone Ventures and Abiomed. The early-stage round in May 2025 drew 12 investors.

For fundraisers
Raising for a company like Reprieve Cardiovascular?

11 investors have backed Reprieve Cardiovascular.

See all 11 investors →

Frequently asked about Reprieve Cardiovascular

How much has Reprieve Cardiovascular raised?
Reprieve Cardiovascular has raised $103.0M in total across 5 recorded funding rounds.
When was Reprieve Cardiovascular's last funding round?
Reprieve Cardiovascular's most recent recorded round was Early Stage VC in May 2025, raising $30.9M.